Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Faciliteren van Samen Beslissen over ziektemodulerende medicijnen voor MS
sep 2020 | Multipele Sclerose